| 1. |
2022
Hsiao SH,Chen WT,Chung CL,Chou YT,Lin SE,Hong SY, Chang JH, Chang TH, Chien LN.
Comparative survival analysis of platinum-based adjuvant chemotherapy for early-stage squamous cell carcinoma and adenocarcinoma of the lung
. Cancer Med
.2022
;(10):2067-2078
|
|
| 2. |
2022
Chang JH,Chiou JF,Hung CS,Liu MC,Chang HW,Hong SY, Wang CY, Lin YL, Hsieh YC, Chung CL, Su YS, Hsiao SS, Liu D, Liang JJ, Liao CC, Chang CS, Lai KS, Chuang HC, Chien KL, Wu WC, Lee YG, Lin SE, Shen YK, Hsu CF, Wang JC, Hsiao SH.
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan.
. Vaccines (Basel)
.2022
;(2):312-.
|
|
| 3. |
2022
Cheng CY,Fang TC,Liao HW,Chen TH,Chang JH,Lin YC, Kao CC, Liu MC, Chang HW, Hung CS, Wang JC, Hsiao SH, Sue YM.
The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection
. Vaccines (Basel)
.2022
;(2):338-.
|
|
| 4. |
2022
Cheng CY,Hsiao SH,Fang TC,Lin YC,Wang JC,Hung CS, Chen TH, Sue YM.
SARS-CoV2 Antibody Response After a Third Dose of Heterologous ChAdOx1 nCoV-19 and Moderna Vaccine in Chronic Dialysis Patients.
. J Infect
.2022
;(6):e98-e100
|
|
| 5. |
2022
Lim HG,Hsiao SH,Fann YC,Lee YG.
Robust Mutation Profiling of SARS-CoV-2 Variants from Multiple Raw Illumina Sequencing Data with Cloud Workflow
. Genes (Basel)
.2022
;(4):686-.
|
|
| 6. |
2022
Hong SY,Lu YC,Hsiao SH,Kao YR,Lee MH,Lin YP, Wang CY, Wu CW.
Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma
. Oncogene
.2022
;(13):1907-1917
|
|
| 7. |
2022
Chang YC,Hsing YC,Chiu YW,Shih CC,Lin JH,Hsiao SH, Sakai K, Ko KH, Chen CY.
Deep Multi-Objective Learning from Low-Dose CT for Automatic Lung-RADS Report Generation
. J Pers Med
.2022
;(3):417-.
|
|
| 8. |
2021
Lim HG,Hsiao SH,Lee YG.
Orchestrating an Optimized Next-Generation Sequencing-Based Cloud Workflow for Robust Viral Identification during Pandemics
. Biology (Basel)
.2021
;(10):1023-.
|
|
| 9. |
2021
Disruption of Cytosolic Folate Integrity Aggravates Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Modulates Metastatic Properties in Non-Small-Cell Lung Cancer Cells
. Int J Mol Sci .
.2021
|
|
| 10. |
2021
Chen WL,Chen MC,Hsu SF,Hsiao SH,Chung CL.
HDAC Inhibitor Abrogates LTA-Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis
. Pharmaceuticals (Basel)
.2021
;(6):585-.
|
|
| 11. |
2021
Cheng-Yi Wang ,Meng-HsuanLee,Yu-RungKao, Shih-Hsin Hsiaod,Shiao-YaHong,Cheng-Wen Wu.
Alisertib inhibits migration and invasion of EGFR-TKI resistant cells by partially reversing the epithelial-mesenchymal transition
. Biochim Biophys Acta Mol Cell Res
.2021
|
|
| 12. |
2020
Kuo MH,Lee AC,Hsiao SH,Lin SE,Chiu YF,Yang LH, Yu CC, Chiou SH, Huang HN, Ko JC, Chou YT.
Cross-talk between SOX2 and TGFβ Signaling Regulates EGFR-TKI Tolerance and Lung Cancer Dissemination
. Cancer Res
.2020
;(20):4426-4438
|
|
| 13. |
2017
Wen Hwang,Yu-Fan Chiu,Ming-Han Kuo,Kuan-Lin Lee ,An-Chun Lee,Yu CC, Chang JL, Huang WC, Hsiao SH, Lin SE, Chou YT.
Expression of Neuroendocrine Factor VGF in Lung Cancer Cells Confers Resistance to EGFR Kinase Inhibitors and Triggers Epithelial-to-Mesenchymal Transition
. Cancer Res .
.2017
|
|
| 14. |
2017
Hsiao SH,Chou YT,Lin SE,Hsu RC,Chung CL,Kao YR, Liu HE, Wu CW.
Brain metastases in patients with non-small cell lung cancer: the role of mutated-EGFRs with an exon 19 deletion or L858R point mutation in cancer cell dissemination.
. Oncotarget.
.2017
;(32):53405-43418
|
|
| 15. |
2017
Hwang W,Chiu YF,Kuo MH,Lee KL,Lee AC,Yu CC, Chang JL, Huang WC, Hsiao SH, Lin SE, Chou YT.
Expression of Neuroendocrine Factor VGF in Lung Cancer Cells Confers Resistance to EGFR Kinase Inhibitors and Triggers Epithelial-to-Mesenchymal Transition.
. Cancer Res
.2017
;(11):3013-3026
|
|
| 16. |
2015
Chiu CH,Yang CT, ,Shih JY, ,Huang MS, ,Su WC, ,Lai RS, Wang CC, Hsiao SH, Lin YC, Ho CL, Hsia TC, Wu MF, Lai CL, Lee KY, Lin CB, Yu-Wung Yeh D, Chuang CY, Chang FK, Tsai CM, Perng RP, Chih-Hsin Yang J..
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations.
. J Thorac Oncol
.2015
;(5):793-9
|
|
| 17. |
2015
Chen WL,Sheu JR,Chen RJ,Hsiao SH,Hsiao CJ,Chou YC, Chung CL, Hsiao G.
Mycobacterium tuberculosis Upregulates TNF-α Expression via TLR2/ERK Signaling and Induces MMP-1 and MMP-9 Production in Human Pleural Mesothelial Cells.
. PLoS One
.2015
;(10):0137979
|
|
| 18. |
2014
Chen WL,Sheu JR,Hsiao CJ,Hsiao SH,Chung CL,Hsiao G.
Histone Deacetylase Inhibitor Impairs Plasminogen Activator Inhibitor-1 Expression via Inhibiting TNF-α-Activated
. Biomed Res Int.
.2014
;(2014)
|
|